Tumour-Agnostic Therapy for Pancreatic Cancer and Biliary Tract Cancer.

Diagnostics (Basel) · 2021 · PMC7914923 · PMID 33562094

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Since crossover was allowed in this study, there was a positive trend in the survival of the ivosidenib group, but the difference was not statistically significant.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.